Actinium Pharmaceuticals, Inc. (ATNM)

1.425 0.00 (0.00%) USD  |  NYAM  |  Dec 10, 10:01
More

Actinium Pharmaceuticals EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for ATNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Arcus Biosciences, Inc. Upgrade
Apyx Medical Corp. Upgrade
AbbVie, Inc. Upgrade
Karyopharm Therapeutics, Inc. --
NovaBay Pharmaceuticals, Inc. --